1. Home
  2. INBS vs CANF Comparison

INBS vs CANF Comparison

Compare INBS & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intelligent Bio Solutions Inc.

INBS

Intelligent Bio Solutions Inc.

N/A

Current Price

$1.65

Market Cap

6.5M

Sector

Health Care

ML Signal

N/A

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

N/A

Current Price

$2.23

Market Cap

6.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INBS
CANF
Founded
2016
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
6.7M
IPO Year
2019
2011

Fundamental Metrics

Financial Performance
Metric
INBS
CANF
Price
$1.65
$2.23
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $50.00
AVG Volume (30 Days)
118.6K
★ 211.9K
Earning Date
05-08-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,980,484.00
N/A
Revenue This Year
$778.48
$2,715,455.50
Revenue Next Year
N/A
$101.06
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.17
52 Week High
$24.90
$10.40

Technical Indicators

Market Signals
Indicator
INBS
CANF
Relative Strength Index (RSI) 31.09 33.50
Support Level $1.52 $2.16
Resistance Level $2.45 $2.39
Average True Range (ATR) 0.13 0.08
MACD -0.05 0.02
Stochastic Oscillator 4.62 24.00

Price Performance

Historical Comparison
INBS
CANF

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: